AUROBINDO PHARMA LTDמעודכן AUROPHARMA 1 YR target 1731
The stock has competed rounding bottom or CUP pattern on weekly chart on LTH of 1064 made in YR 2021 with a low of 397 and successfully retested 1064 after breaking it.
Target 1064 + (1064-397=~667) => ~1731, timeframe must be within a year with intermediate targets of 1252 and 1409 and 1664.
looks a good buy in the range of 1180-1210 for said targets.... keep trailing stop loss as it reaches higher.
* It is not a trade advise but technical analysis shared based on my understanding of patterns and personal experiences, please take any trade at your own risk.
Target 1064 + (1064-397=~667) => ~1731, timeframe must be within a year with intermediate targets of 1252 and 1409 and 1664.
looks a good buy in the range of 1180-1210 for said targets.... keep trailing stop loss as it reaches higher.
* It is not a trade advise but technical analysis shared based on my understanding of patterns and personal experiences, please take any trade at your own risk.
הערה
Target of 1252 achieved :)עסקה פעילה
1300 crossed and now 1409 must be on radar.עסקה פעילה
1408.75 has been the day high, 2nd target of 1409 is also done with this.From here 1664 is the next target.
הערה
Back towards LTH 1409, closing above this number will trigger another up move, below that it will be dangling.הערה
Very good monthly closing, 1471 is the next hurdle where we can see profit booking or resistance but one it is over then 1664 will be the target followed by 1724.הערה
Good weekly closing 1471 is ON.הערה
Bingo: 1472 is the day high for today's run and then there was profit booking, numbers are working as expected, closing above this number will open 1664.הערה
another new LTH 1487 :)הערה
New LTH : 1537 Bingo :)
הערה
300 points of run so far which is more than 25% since the post created, even more if I calculate the low made after the post 1180.הערה
new LTH 1580
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.